JP2005508368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508368A5 JP2005508368A5 JP2003541772A JP2003541772A JP2005508368A5 JP 2005508368 A5 JP2005508368 A5 JP 2005508368A5 JP 2003541772 A JP2003541772 A JP 2003541772A JP 2003541772 A JP2003541772 A JP 2003541772A JP 2005508368 A5 JP2005508368 A5 JP 2005508368A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- composition
- alkyl
- composition according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34802001P | 2001-11-08 | 2001-11-08 | |
| PCT/US2002/035900 WO2003039480A2 (en) | 2001-11-08 | 2002-11-08 | Method of treating disorder related to high cholesterol concentration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508368A JP2005508368A (ja) | 2005-03-31 |
| JP2005508368A5 true JP2005508368A5 (enExample) | 2006-01-12 |
Family
ID=23366328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541772A Pending JP2005508368A (ja) | 2001-11-08 | 2002-11-08 | 高コレステロール濃度に関連した疾患の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1450816A4 (enExample) |
| JP (1) | JP2005508368A (enExample) |
| CA (1) | CA2466033A1 (enExample) |
| TW (1) | TW200300078A (enExample) |
| WO (1) | WO2003039480A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7078396B2 (en) | 2001-05-03 | 2006-07-18 | Arch Development Corporation | Method of treating disorder related to high cholesterol concentration |
| WO2006047022A1 (en) | 2004-10-25 | 2006-05-04 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis |
| US8399441B2 (en) | 2004-10-25 | 2013-03-19 | Virginia Commonwealth University | Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| TW200619191A (en) | 2004-10-27 | 2006-06-16 | Sankyo Co | Phenyl compounds with more than 2 substitutes |
| EP2091926B1 (en) | 2006-11-13 | 2015-10-21 | Novartis AG | Substituted pyrazole and triazole compounds as ksp inhibitors |
| US8829213B2 (en) | 2009-07-29 | 2014-09-09 | The University Of Chicago | Liver X receptor agonists |
| US9034859B2 (en) | 2011-04-06 | 2015-05-19 | Virginia Commonwealth University | Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation |
| CA2848212C (en) | 2011-09-08 | 2022-03-29 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| PT2968369T (pt) | 2013-03-13 | 2018-12-05 | Sage Therapeutics Inc | Esteroides neuroativos e métodos para o seu uso |
| CN119269811A (zh) * | 2013-03-13 | 2025-01-07 | 萨奇治疗股份有限公司 | 神经活性类固醇、组合物、及其用途 |
| JP2016193835A (ja) * | 2013-09-04 | 2016-11-17 | 学校法人常翔学園 | 核内受容体肝臓ｘ受容体アゴニスト |
| HRP20220112T1 (hr) | 2013-12-24 | 2022-04-15 | Virginia Commonwealth University | Upotreba oksidacijskog sulfata kolesterola (ocs) za liječenje akutne insuficijencije jetre |
| US10259840B2 (en) | 2014-06-18 | 2019-04-16 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| HUE071964T2 (hu) | 2015-07-06 | 2025-10-28 | Sage Therapeutics Inc | Oxiszterolok és alkalmazási eljárásaik |
| CA2991311C (en) | 2015-07-06 | 2025-05-06 | Sage Therapeutics, Inc. | OXYSTEROLS AND THEIR METHODS OF USE |
| EP3828194B1 (en) | 2015-07-06 | 2025-04-16 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| SMT202200300T1 (it) | 2016-04-01 | 2022-09-14 | Sage Therapeutics Inc | Ossisteroli e relativi metodi d'uso |
| WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| ES2884071T3 (es) | 2016-07-07 | 2021-12-10 | Sage Therapeutics Inc | 24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA |
| EP3494125B1 (en) | 2016-08-02 | 2022-06-22 | Virginia Commonwealth University | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide |
| ES2935057T3 (es) | 2016-09-30 | 2023-03-01 | Sage Therapeutics Inc | C7 oxisteroles sustituidos y estos compuestos para su uso como moduladores de la NMDA |
| RU2019115113A (ru) | 2016-10-18 | 2020-11-24 | Сейдж Терапьютикс, Инк. | Оксистеролы и способы их применения |
| KR20230051723A (ko) | 2016-10-18 | 2023-04-18 | 세이지 테라퓨틱스, 인크. | 옥시스테롤 및 그의 사용 방법 |
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4976857A (enExample) * | 1972-12-06 | 1974-07-24 | ||
| US3963765A (en) * | 1973-04-01 | 1976-06-15 | Yehuda Mazur | Preparation of derivatives of cholesterol |
| US4217288A (en) * | 1977-03-24 | 1980-08-12 | Wisconsin Alumni Research Foundation | Anti-vitamin D compounds |
| JPS61254599A (ja) * | 1985-05-07 | 1986-11-12 | Sumitomo Pharmaceut Co Ltd | コレステロ−ルのフツ素誘導体 |
| IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
| IT1255241B (it) * | 1992-07-22 | 1995-10-20 | Simos Contos | Derivato di acido biliare e suo uso in terapia |
| CN1187364C (zh) * | 1999-04-30 | 2005-02-02 | 亚其发展公司 | 类固醇衍生物 |
| JP4309661B2 (ja) * | 2001-05-03 | 2009-08-05 | ザ ユニバーシティー オブ シカゴ | 肝臓ｘ受容体 |
-
2002
- 2002-11-08 WO PCT/US2002/035900 patent/WO2003039480A2/en not_active Ceased
- 2002-11-08 EP EP02802882A patent/EP1450816A4/en not_active Withdrawn
- 2002-11-08 CA CA002466033A patent/CA2466033A1/en not_active Abandoned
- 2002-11-08 TW TW091132850A patent/TW200300078A/zh unknown
- 2002-11-08 JP JP2003541772A patent/JP2005508368A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508368A5 (enExample) | ||
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| HRP20240157T1 (hr) | Deuterirani derivati lanifibranora | |
| JP2008522981A5 (enExample) | ||
| HUP0001894A2 (hu) | N-Piperidino-3-pirazolkarboxamid-származékot, sóját vagy szolvátját tartalmazó orálisan adagolható gyógyszerkészítmény | |
| JP2007502861A5 (enExample) | ||
| JP2008509166A5 (enExample) | ||
| JP2004529125A5 (enExample) | ||
| JP2003528852A5 (enExample) | ||
| EP1797878A3 (en) | Benzothiazole derivatives | |
| EP2210892A3 (en) | Neurologically-active compounds | |
| JP2005527576A5 (enExample) | ||
| JP2004532828A5 (enExample) | ||
| JP2007505044A5 (enExample) | ||
| JP2021522327A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| US20180370960A1 (en) | Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein | |
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| RU2222537C2 (ru) | Новые производные морфолина, способ их получения и содержащие их фармацевтические композиции | |
| US7015238B2 (en) | Crystalline organic acid salt of amlodipine | |
| RU2001116601A (ru) | Новые производные пиримидина и способы их получения | |
| JP2005516066A5 (enExample) | ||
| RU2005117626A (ru) | Улучшенные готовые лекарственные формы, содержащие замещенные производные имидазола | |
| JP2022501315A5 (enExample) | ||
| EP2599767A1 (en) | Phenylbutyl-derivatives |